z-logo
open-access-imgOpen Access
Bevacizumab in combination with metronomic oral cyclophosphamide: an effective and well-tolerated treatment for patients with recurrent ovarian cancer
Publication year - 2020
Publication title -
european journal of gynaecological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.15
H-Index - 45
eISSN - 2709-0086
pISSN - 0392-2936
DOI - 10.31083/j.ejgo.2020.03.5267
Subject(s) - medicine , bevacizumab , ovarian cancer , cyclophosphamide , oncology , cancer , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom